Literature DB >> 11379794

Regulation of blood-brain barrier permeability.

W G Mayhan1.   

Abstract

The blood-brain barrier minimizes the entry of molecules into brain tissue. This restriction arises by the presence of tight junctions (zonulae occludens) between adjacent endothelial cells and a relative paucity of pinocytotic vesicles within endothelium of cerebral arterioles, capillaries, and venules. Many types of stimuli can alter the permeability characteristics of the blood-brain barrier. Acute increases in arterial blood pressure beyond the autoregulatory capacity of cerebral blood vessels, application of hyperosmolar solutions, application of various inflammatory mediators known to be elevated during brain injury, and/or activation of blood-borne elements such as leukocytes can produce changes in permeability of the blood-brain barrier. The second messenger systems that account for increases in permeability of the blood-brain barrier during pathophysiologic conditions, however, remain poorly defined. This review will summarize studies that have examined factors that influence disruption of the blood-brain barrier, and will discuss the contribution of various cellular second messenger pathways in disruption of the blood-brain barrier during pathophysiologic conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11379794     DOI: 10.1111/j.1549-8719.2001.tb00160.x

Source DB:  PubMed          Journal:  Microcirculation        ISSN: 1073-9688            Impact factor:   2.628


  26 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 2.  New technologies for drug delivery across the blood brain barrier.

Authors:  A V Kabanov; E V Batrakova
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

3.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

Review 4.  Dynamics of CNS barriers: evolution, differentiation, and modulation.

Authors:  N Joan Abbott
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

5.  Differential effects of nitric oxide on blood-brain barrier integrity and cerebral blood flow in intracerebral C6 gliomas.

Authors:  Astrid Weyerbrock; Stuart Walbridge; Joseph E Saavedra; Larry K Keefer; Edward H Oldfield
Journal:  Neuro Oncol       Date:  2010-11-01       Impact factor: 12.300

6.  Contribution of nitric oxide synthase (NOS) activity in blood-brain barrier disruption and edema after acute ischemia/reperfusion in aortic coarctation-induced hypertensive rats.

Authors:  Mohammad Taghi Mohammadi; Seyed Mostafa Shid Moosavi; Gholam Abbas Dehghani
Journal:  Iran Biomed J       Date:  2011

7.  Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo.

Authors:  Lingyan Shi; Min Zeng; Bingmei M Fu
Journal:  J Neurosci Res       Date:  2014-07-28       Impact factor: 4.164

Review 8.  Blood-brain barrier dysfunction following traumatic brain injury.

Authors:  Himakarnika Alluri; Katie Wiggins-Dohlvik; Matthew L Davis; Jason H Huang; Binu Tharakan
Journal:  Metab Brain Dis       Date:  2015-01-28       Impact factor: 3.584

Review 9.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

10.  Endothelial transient receptor potential conical channel (TRPC)-3 activation induces vasogenic edema formation in the rat piriform cortex following status epilepticus.

Authors:  Hea Jin Ryu; Ji-Eun Kim; Yeon-Joo Kim; Ji-Yang Kim; Won I L Kim; So-Yeon Choi; Min-Ju Kim; Tae-Cheon Kang
Journal:  Cell Mol Neurobiol       Date:  2013-03-26       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.